Following a positive a positive European Medicines Agency recommendation in July, the European Commission (EC) has now ...

Johnson & Johnson has halted its plan to implement a 340B rebate model after the Health Resources and Services Administration ...

Bristol Myers Squibb won a legal victory as a New York judge dismissed a $6.4 billion lawsuit filed by UMB Bank on behalf of ...

ARS Pharmaceuticals' Neffy, the first needle-free epinephrine nasal spray, is poised to significantly impact the treatment of ...

Recipharm and Exela Pharma Sciences have formed an exclusive strategic alliance to expand sterile manufacturing capabilities ...

Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the ...

Rivus Pharmaceuticals announced new Phase IIa HuMAIN study data for HU6, its investigational treatment for obesity-related ...

Kezar Life Sciences saw its share tumble more than 42% to 40.77 yesterday, after it revealed it was voluntarily pausing ...

Boston, USA-based biotech Aktis Oncology, which is targeting alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced the successful closing of an oversubscribed and upsized ...

The Russian government has finalized the rules for granting preference to domestic drugs in public procurements, which will ...

Germany-headquartered CNS drug specialist Neuraxpharm Group today announced the launch of Neuraxpharm Middle East to cover ...

AstronauTx, a biotech developing novel treatments for Alzheimer's disease and other neurodegenerative disorders, has ...